Klox Technologies Inc a Canada-based regenerative medicine company focused on the development and commercialisation of its proprietary fluorescent light energy biomodulation System (FB System) in dermatology, wound care, and animal health, announced yesterday that it has named Domenic Serafino and Dr Richard Markoff as its new directors.
Serafino is a medical device veteran, with more than 25 years of experience. Presently, he serves as chairman and CEO of Venus Concept with direct operations in 27 of these markets and over 500 employees. He brings extensive experience in sales, marketing and global operations.
Dr Markoff has more than 25 years' experience as a supply chain executive. He is co-founder and partner at Innovobot and earlier managed Global Supply Chain Standards at L'Oreal cosmetics. He holds a PhD in Supply Chain Management and is a lecturer and researcher at Ecole polytechnique federale de Lausanne and the International Institute for Management Development in Switzerland.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system